Business

In an increasingly health-conscious world, traditional fast-food chains are undergoing a radical transformation, one sip at a time. The rise of Gen Z consumers has compelled these establishments to pivot from their norm—greasy burgers and salty fries—to more vibrant, flavored beverages. With millennials and Gen Z eager for novelty, companies are going beyond classic soda
0 Comments
As the dust settles following the U.S. Food and Drug Administration’s (FDA) recent regulations targeting compounding pharmacies, the landscape of weight-loss drugs like Eli Lilly’s Zepbound and diabetes medications such as Mounjaro appears murkier than ever. A striking fact remains: many compounding pharmacies continue to produce versions of these drugs even as the FDA has
0 Comments
PepsiCo’s recent decision to acquire the burgeoning prebiotic soda brand, Poppi, for an astounding $1.95 billion (with net costs effectively coming to $1.65 billion) begs a deep dive into the implications of this strategic move. As ordinary soda consumption continues to plummet, it’s imperative to question why the giant soda manufacturers are pivoting so dramatically.
0 Comments